182 related articles for article (PubMed ID: 38812509)
21. Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data.
Wang Y; Yuan Z; Zhu Q; Ma J; Lu Q; Xiao Z
J Gastrointest Oncol; 2024 Feb; 15(1):377-396. PubMed ID: 38482234
[TBL] [Abstract][Full Text] [Related]
22. Exploring the Relevance of Disulfidptosis to the Pathophysiology of Ulcerative Colitis by Bioinformatics Analysis.
Xiong Z; Fang Y; Lu S; Sun Q; Sun Y; Yang P; Huang J
J Inflamm Res; 2024; 17():2757-2774. PubMed ID: 38737111
[TBL] [Abstract][Full Text] [Related]
23. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis.
Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L
Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890
[TBL] [Abstract][Full Text] [Related]
24. Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory roles.
Luo Z; Yan S; Chao Y; Shen M
Heliyon; 2024 Apr; 10(7):e28935. PubMed ID: 38601640
[TBL] [Abstract][Full Text] [Related]
25. Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease.
Darci-Maher N; Alvarez M; Arasu UT; Selvarajan I; Lee SHT; Pan DZ; Miao Z; Das SS; Kaminska D; Örd T; Benhammou JN; Wabitsch M; Pisegna JR; Männistö V; Pietiläinen KH; Laakso M; Sinsheimer JS; Kaikkonen MU; Pihlajamäki J; Pajukanta P
EBioMedicine; 2023 Jun; 92():104620. PubMed ID: 37224770
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
27. A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing.
Liao Z; Cheng Y; Zhang H; Jin X; Sun H; Wang Y; Yan J
Front Cell Dev Biol; 2023; 11():1308352. PubMed ID: 38033866
[No Abstract] [Full Text] [Related]
28. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
29. Analysis of network expression and immune infiltration of disulfidptosis-related genes in chronic obstructive pulmonary disease.
Liu Y; Zhu T; Wang J; Cheng Y; Zeng Q; You Z; Dai G
Immun Inflamm Dis; 2024 Apr; 12(4):e1231. PubMed ID: 38578019
[TBL] [Abstract][Full Text] [Related]
30. Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.
He R; Guan C; Zhao X; Yu L; Cui Y
Front Immunol; 2024; 15():1364442. PubMed ID: 38524129
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework.
Zhao S; Wang L; Ding W; Ye B; Cheng C; Shao J; Liu J; Zhou H
Front Endocrinol (Lausanne); 2023; 14():1180404. PubMed ID: 37152941
[TBL] [Abstract][Full Text] [Related]
32. Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.
Guo J; Zhou Y; Cheng Y; Fang W; Hu G; Wei J; Lin Y; Man Y; Guo L; Sun M; Cui Q; Li J
Cell Physiol Biochem; 2018; 45(4):1487-1505. PubMed ID: 29466788
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive bioinformatics analysis on multiple Gene Expression Omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Huang S; Sun C; Hou Y; Tang Y; Zhu Z; Zhang Z; Zhang Y; Wang L; Zhao Q; Chen MG; Guo Z; Wang D; Ju W; Zhou Q; Wu L; He X
Sci Rep; 2018 May; 8(1):7630. PubMed ID: 29769552
[TBL] [Abstract][Full Text] [Related]
34. Weighted Gene Co-Expression Network Analysis of Immune Infiltration in Nonalcoholic Fatty Liver Disease.
Wang Z; Xia Y; Pan Y; Zhang L; Tang F; Yu X; Yang Z; Wang D; Yang L; Jia J; Yuan G
Endocr Metab Immune Disord Drug Targets; 2023; 23(9):1173-1185. PubMed ID: 36503447
[TBL] [Abstract][Full Text] [Related]
35. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract][Full Text] [Related]
36. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
[TBL] [Abstract][Full Text] [Related]
37. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD.
Zhu M; Wang Q; Zhou W; Liu T; Yang L; Zheng P; Zhang L; Ji G
Sci Rep; 2018 May; 8(1):7628. PubMed ID: 29769539
[TBL] [Abstract][Full Text] [Related]
39. Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis.
He W; Huang C; Zhang X; Wang D; Chen Y; Zhao Y; Li X
Endocrine; 2021 Jul; 73(1):52-64. PubMed ID: 33837926
[TBL] [Abstract][Full Text] [Related]
40. Using bioinformatics and systems biology methods to identify the mechanism of interaction between COVID-19 and nonalcoholic fatty liver disease.
Dong W; Jin Y; Shi H; Zhang X; Chen J; Jia H; Zhang Y
Medicine (Baltimore); 2023 Jun; 102(23):e33912. PubMed ID: 37335656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
